Genenta Science S.p.A.
GNTA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $49 | $77 | $52 | $82 |
| - Cash | $5 | $5 | $6 | $4 |
| + Debt | $8 | $0 | $0 | $0 |
| Enterprise Value | $51 | $72 | $46 | $78 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$5 | -$4 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$5 | -$4 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -0.27 | -0.22 | -0.27 |
| % Growth | 25.9% | -22.7% | 18.5% | – |
| Operating Cash Flow | -$0 | -$6 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$6 | -$0 | -$0 |